LJI308 is a potent pan-ribosomal S6 kinase (RSK) inhibitor, with IC50s of 6 nM, 4 nM, and 13 nM for RSK1, RSK2, and RSK3, respectively. LJI308 inhibits the phosphorylation of RSK (T359/S363) and YB-1 (S102) after irradiation, treatment with EGF, and in cells expressing a KRAS mutation[1][2].
Molecular Weight:
368.38
Purity:
99.07
CAS Number:
[1627709-94-7]
Formula:
C21H18F2N2O2
Target:
Ribosomal S6 Kinase (RSK),YB-1
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted